Actinium Pharmaceuticals, Inc.
ATNM- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001388320
No open-market purchases or sales by Actinium Pharmaceuticals, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $5.18M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Actinium Pharmaceuticals, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 40 | 37 | −3 |
| Shares | 1.31M | 1.73M | +416.8K (+31.8%) |
| Value | $9.99M | $13.7M | +$3.68M (+36.8%) |
New holders (4)
Institutions that held Actinium Pharmaceuticals, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| State Street Corp | 55,292 | $437.0K | 0.00% |
| Pinnacle Associates Ltd | 34,333 | $272.0K | 0.00% |
| Emfo, LLC | 1,666 | $13.0K | 0.01% |
| Tarbox Family Office, Inc. | 332 | $3.00K | 0.00% |
Sold out (7)
Institutions that held Actinium Pharmaceuticals, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Silverarc Capital Management, LLC | 45,910 | $350.0K |
| Marshall Wace, LLP | 13,019 | $99.0K |
| Group One Trading, L.P. | 4,385 | $33.0K |
| Spire Wealth Management | 1,800 | $15.0K |
| Sowell Financial Services LLC | 636 | $5.00K |
| IFP Advisors, Inc | 133 | $1.00K |
| Valeo Financial Advisors, LLC | 50 | $0 |